CompletedNCT00000908
A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts
Studying Pneumocystosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Susan Koletar
- Enrollment
- 250 target
- Eligibility
- 13 years · All sexes
Study locations (30)
- Univ of Alabama at Birmingham, Birmingham, Alabama, United States
- Kaiser Foundation Hosp, Harbor City, California, United States
- Kaiser Permanente LAMC, Los Angeles, California, United States
- Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
- Willow Clinic, Menlo Park, California, United States
- Univ of California / San Diego Treatment Ctr, San Diego, California, United States
- San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco, California, United States
- San Francisco Gen Hosp, San Francisco, California, United States
- Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium, San Jose, California, United States
- Marin County Specialty Clinic, San Rafael, California, United States
- San Mateo AIDS Program / Stanford Univ, Stanford, California, United States
- Stanford Univ Med Ctr, Stanford, California, United States
- Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
- Howard Univ, Washington D.C., District of Columbia, United States
- Univ of Miami School of Medicine, Miami, Florida, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00000908 on ClinicalTrials.govOther trials for Pneumocystosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT04851015Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii PneumoniaTodd C. Lee MD MPH FIDSA
- RECRUITINGPHASE4NCT06499233Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic DiseaseTongji Hospital
- ACTIVE NOT RECRUITINGNCT06431958Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis JiroveciiUniversity Hospital, Brest
- RECRUITINGPHASE2NCT05835479Rezafungin for Treatment of Pneumocystis Pneumonia in HIV AdultsMundipharma Research Limited
- RECRUITINGNCT07269314Introduction of Polymerase Chain Reaction (PCR) in Microbiology and ParasitologyFondazione IRCCS Policlinico San Matteo di Pavia
- RECRUITINGNCT06691321Caspofungin for Pneumocystis Pneumonia in PLWHIV.Instituto Nacional de Enfermedades Respiratorias
- ENROLLING BY INVITATIONNANCT03856229Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDSCentro de Investigación en. Enfermedades Infecciosas, Mexico